-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] In recent years, the state has begun to further meet the people's needs for convenient medical services by vigorously supporting the innovation of the "Internet +" medical service model
.
In this context, the rapid development of Internet medical care has played a driving role in pharmaceutical e-commerce.
Pharmaceutical companies have begun to develop digital marketing, and Internet companies have also continued to step into the blue ocean of Internet medicine
.
It should be noted that, at the same time, the cooperation between pharmaceutical companies and Internet companies is gradually becoming a general trend in the industry
.
Recently, Yaodou.
com and Shenzhen Xingyin Pharmaceutical Co.
, Ltd.
signed a strategic cooperation agreement in Beijing, and cooperated on the business such as Xingyin Medicine Maizhiling tablets and other advantageous household standing medicine landing terminals
.
It is understood that Xingyin Pharmaceutical Group is a high-tech enterprise integrating the research and development, production and operation of pharmaceutical products
.
As a large domestic Internet pharmaceutical company, Yaodou.
com has formed a closed loop of pharmaceutical industry transactions of digital distribution, new pharmaceutical retail and cloud services based on the supply chain advantages accumulated in the past ten years and the in-depth service capabilities of the pharmaceutical industry.
The Internet channel and national retail channel sales service provider of related advantageous varieties of enterprises
.
In fact, as digitization and intelligence have increasingly become emerging forces in the transformation and upgrading of China's medical system, the integration and innovation of the Internet and the pharmaceutical industry has begun to become a new trend in the current industry
.
In addition to the above-mentioned companies, many companies have been cooperating with Internet companies in recent years to make arrangements for digital transformation
.
Such as Tigermed also announced last year that it would sign a strategic cooperation agreement with Zhiyun Health in Hangzhou
.
According to the agreement, the two parties will rely on their respective business advantages to carry out in-depth cooperation in assisting the digitalization of pharmaceutical research and development, building a service platform for the whole life cycle of medical products and patient management, etc.
, and jointly create a new future of digital health care
.
It is worth mentioning that in addition to domestic pharmaceutical companies, multinational pharmaceutical companies are also frequently cooperating with Internet companies to promote digital development
.
For example, in November 2021, Sanofi reached a strategic cooperation with Olive Branch Health at the 4th China International Import Expo, and decided to jointly explore and create a digital ecology of vaccines
.
Specifically, it will mainly focus on improving the public's awareness and acceptance of vaccines; supporting the improvement of the digital service capabilities of the public health system, exploring innovative solutions for vaccination services such as unmanned vaccination cabins, and improving vaccine accessibility
.
In addition, Gilead Sciences has also announced that it will reach a strategic cooperation with JD Health in the field of digital medical health ecology
.
The two parties will deeply explore the innovative practice of "Internet + medical health", and jointly provide more professional, safe and convenient "one-stop" disease management solutions for patients with chronic infectious diseases, and accelerate the help of HIV, chronic viral hepatitis and other infectious diseases.
Advancement of disease prevention and control work
.
In general, domestic and foreign pharmaceutical companies are currently using artificial intelligence, machine learning, big data, electronic data collection and other technologies and platforms to accelerate the efficiency of drug research and development, further promote the process of clinical trials, and bring doctors and patients closer.
From the perspective of the relationship between them, digitalization has become a new engine driving medical service innovation, and is providing strong support for the establishment and improvement of a high-quality medical and health service system
.
In the future, under this background, it will become the norm for pharmaceutical companies to join hands with Internet companies
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
In this context, the rapid development of Internet medical care has played a driving role in pharmaceutical e-commerce.
Pharmaceutical companies have begun to develop digital marketing, and Internet companies have also continued to step into the blue ocean of Internet medicine
.
It should be noted that, at the same time, the cooperation between pharmaceutical companies and Internet companies is gradually becoming a general trend in the industry
.
Recently, Yaodou.
com and Shenzhen Xingyin Pharmaceutical Co.
, Ltd.
signed a strategic cooperation agreement in Beijing, and cooperated on the business such as Xingyin Medicine Maizhiling tablets and other advantageous household standing medicine landing terminals
.
It is understood that Xingyin Pharmaceutical Group is a high-tech enterprise integrating the research and development, production and operation of pharmaceutical products
.
As a large domestic Internet pharmaceutical company, Yaodou.
com has formed a closed loop of pharmaceutical industry transactions of digital distribution, new pharmaceutical retail and cloud services based on the supply chain advantages accumulated in the past ten years and the in-depth service capabilities of the pharmaceutical industry.
The Internet channel and national retail channel sales service provider of related advantageous varieties of enterprises
.
In fact, as digitization and intelligence have increasingly become emerging forces in the transformation and upgrading of China's medical system, the integration and innovation of the Internet and the pharmaceutical industry has begun to become a new trend in the current industry
.
In addition to the above-mentioned companies, many companies have been cooperating with Internet companies in recent years to make arrangements for digital transformation
.
Such as Tigermed also announced last year that it would sign a strategic cooperation agreement with Zhiyun Health in Hangzhou
.
According to the agreement, the two parties will rely on their respective business advantages to carry out in-depth cooperation in assisting the digitalization of pharmaceutical research and development, building a service platform for the whole life cycle of medical products and patient management, etc.
, and jointly create a new future of digital health care
.
It is worth mentioning that in addition to domestic pharmaceutical companies, multinational pharmaceutical companies are also frequently cooperating with Internet companies to promote digital development
.
For example, in November 2021, Sanofi reached a strategic cooperation with Olive Branch Health at the 4th China International Import Expo, and decided to jointly explore and create a digital ecology of vaccines
.
Specifically, it will mainly focus on improving the public's awareness and acceptance of vaccines; supporting the improvement of the digital service capabilities of the public health system, exploring innovative solutions for vaccination services such as unmanned vaccination cabins, and improving vaccine accessibility
.
In addition, Gilead Sciences has also announced that it will reach a strategic cooperation with JD Health in the field of digital medical health ecology
.
The two parties will deeply explore the innovative practice of "Internet + medical health", and jointly provide more professional, safe and convenient "one-stop" disease management solutions for patients with chronic infectious diseases, and accelerate the help of HIV, chronic viral hepatitis and other infectious diseases.
Advancement of disease prevention and control work
.
In general, domestic and foreign pharmaceutical companies are currently using artificial intelligence, machine learning, big data, electronic data collection and other technologies and platforms to accelerate the efficiency of drug research and development, further promote the process of clinical trials, and bring doctors and patients closer.
From the perspective of the relationship between them, digitalization has become a new engine driving medical service innovation, and is providing strong support for the establishment and improvement of a high-quality medical and health service system
.
In the future, under this background, it will become the norm for pharmaceutical companies to join hands with Internet companies
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
